Global Urology Drugs Market Research Report 2023

The global Urology Drugs market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.

North American market for Urology Drugs is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

Asia-Pacific market for Urology Drugs is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

The key global manufacturers of Urology Drugs include Astellas, Endo, GP Pharm and Tolmar, etc. in 2022, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Urology Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Urology Drugs.

The Urology Drugs market size, estimations, and forecasts are provided in terms of sales volume (MT) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Urology Drugs market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Urology Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.

1.1 Product Overview and Scope of Urology Drugs

1.2 Urology Drugs Segment by Type

1.2.1 Global Urology Drugs Market Value Comparison by Type (2023-2029)

1.2.2 Α (alpha) Blockers

1.2.3 5 α-reductase Inhibitors

1.3 Urology Drugs Segment by Application

1.3.1 Global Urology Drugs Market Value by Application: (2023-2029)

1.3.2 Hospital

1.3.3 Clinic

1.3.4 Others

1.4 Global Urology Drugs Market Size Estimates and Forecasts

1.4.1 Global Urology Drugs Revenue 2018-2029

1.4.2 Global Urology Drugs Sales 2018-2029

1.4.3 Global Urology Drugs Market Average Price (2018-2029)

1.5 Assumptions and Limitations

2.1 Global Urology Drugs Sales Market Share by Manufacturers (2018-2023)

2.2 Global Urology Drugs Revenue Market Share by Manufacturers (2018-2023)

2.3 Global Urology Drugs Average Price by Manufacturers (2018-2023)

2.4 Global Urology Drugs Industry Ranking 2021 VS 2022 VS 2023

2.5 Global Key Manufacturers of Urology Drugs, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Urology Drugs, Product Type & Application

2.7 Urology Drugs Market Competitive Situation and Trends

2.7.1 Urology Drugs Market Concentration Rate

2.7.2 The Global Top 5 and Top 10 Largest Urology Drugs Players Market Share by Revenue

2.7.3 Global Urology Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

2.8 Manufacturers Mergers & Acquisitions, Expansion Plans

3.1 Global Urology Drugs Market Size by Region: 2018 Versus 2022 Versus 2029

3.2 Global Urology Drugs Global Urology Drugs Sales by Region: 2018-2029

3.2.1 Global Urology Drugs Sales by Region: 2018-2023

3.2.2 Global Urology Drugs Sales by Region: 2024-2029

3.3 Global Urology Drugs Global Urology Drugs Revenue by Region: 2018-2029

3.3.1 Global Urology Drugs Revenue by Region: 2018-2023

3.3.2 Global Urology Drugs Revenue by Region: 2024-2029

3.4 North America Urology Drugs Market Facts & Figures by Country

3.4.1 North America Urology Drugs Market Size by Country: 2018 VS 2022 VS 2029

3.4.2 North America Urology Drugs Sales by Country (2018-2029)

3.4.3 North America Urology Drugs Revenue by Country (2018-2029)

3.4.4 U.S.

3.4.5 Canada

3.5 Europe Urology Drugs Market Facts & Figures by Country

3.5.1 Europe Urology Drugs Market Size by Country: 2018 VS 2022 VS 2029

3.5.2 Europe Urology Drugs Sales by Country (2018-2029)

3.5.3 Europe Urology Drugs Revenue by Country (2018-2029)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Urology Drugs Market Facts & Figures by Country

3.6.1 Asia Pacific Urology Drugs Market Size by Country: 2018 VS 2022 VS 2029

3.6.2 Asia Pacific Urology Drugs Sales by Country (2018-2029)

3.6.3 Asia Pacific Urology Drugs Revenue by Country (2018-2029)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.6.13 Philippines

3.7 Latin America Urology Drugs Market Facts & Figures by Country

3.7.1 Latin America Urology Drugs Market Size by Country: 2018 VS 2022 VS 2029

3.7.2 Latin America Urology Drugs Sales by Country (2018-2029)

3.7.3 Latin America Urology Drugs Revenue by Country (2018-2029)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Urology Drugs Market Facts & Figures by Country

3.8.1 Middle East and Africa Urology Drugs Market Size by Country: 2018 VS 2022 VS 2029

3.8.2 Middle East and Africa Urology Drugs Sales by Country (2018-2029)

3.8.3 Middle East and Africa Urology Drugs Revenue by Country (2018-2029)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 U.A.E

4.1 Global Urology Drugs Sales by Type (2018-2029)

4.1.1 Global Urology Drugs Sales by Type (2018-2023)

4.1.2 Global Urology Drugs Sales by Type (2024-2029)

4.1.3 Global Urology Drugs Sales Market Share by Type (2018-2029)

4.2 Global Urology Drugs Revenue by Type (2018-2029)

4.2.1 Global Urology Drugs Revenue by Type (2018-2023)

4.2.2 Global Urology Drugs Revenue by Type (2024-2029)

4.2.3 Global Urology Drugs Revenue Market Share by Type (2018-2029)

4.3 Global Urology Drugs Price by Type (2018-2029)

5.1 Global Urology Drugs Sales by Application (2018-2029)

5.1.1 Global Urology Drugs Sales by Application (2018-2023)

5.1.2 Global Urology Drugs Sales by Application (2024-2029)

5.1.3 Global Urology Drugs Sales Market Share by Application (2018-2029)

5.2 Global Urology Drugs Revenue by Application (2018-2029)

5.2.1 Global Urology Drugs Revenue by Application (2018-2023)

5.2.2 Global Urology Drugs Revenue by Application (2024-2029)

5.2.3 Global Urology Drugs Revenue Market Share by Application (2018-2029)

5.3 Global Urology Drugs Price by Application (2018-2029)

6.1 Astellas

6.1.1 Astellas Corporation Information

6.1.2 Astellas Description and Business Overview

6.1.3 Astellas Urology Drugs Sales, Revenue and Gross Margin (2018-2023)

6.1.4 Astellas Urology Drugs Product Portfolio

6.1.5 Astellas Recent Developments/Updates

6.2 Endo

6.2.1 Endo Corporation Information

6.2.2 Endo Description and Business Overview

6.2.3 Endo Urology Drugs Sales, Revenue and Gross Margin (2018-2023)

6.2.4 Endo Urology Drugs Product Portfolio

6.2.5 Endo Recent Developments/Updates

6.3 GP Pharm

6.3.1 GP Pharm Corporation Information

6.3.2 GP Pharm Description and Business Overview

6.3.3 GP Pharm Urology Drugs Sales, Revenue and Gross Margin (2018-2023)

6.3.4 GP Pharm Urology Drugs Product Portfolio

6.3.5 GP Pharm Recent Developments/Updates

6.4 Tolmar

6.4.1 Tolmar Corporation Information

6.4.2 Tolmar Description and Business Overview

6.4.3 Tolmar Urology Drugs Sales, Revenue and Gross Margin (2018-2023)

6.4.4 Tolmar Urology Drugs Product Portfolio

6.4.5 Tolmar Recent Developments/Updates

7.1 Urology Drugs Industry Chain Analysis

7.2 Urology Drugs Key Raw Materials

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Urology Drugs Production Mode & Process

7.4 Urology Drugs Sales and Marketing

7.4.1 Urology Drugs Sales Channels

7.4.2 Urology Drugs Distributors

7.5 Urology Drugs Customers

8.1 Urology Drugs Industry Trends

8.2 Urology Drugs Market Drivers

8.3 Urology Drugs Market Challenges

8.4 Urology Drugs Market Restraints

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

List of Tables

    Table 1. Global Urology Drugs Market Value Comparison by Type (2023-2029) & (US$ Million)

    Table 2. Global Urology Drugs Market Value Comparison by Application (2023-2029) & (US$ Million)

    Table 3. Global Urology Drugs Market Competitive Situation by Manufacturers in 2022

    Table 4. Global Urology Drugs Sales (MT) of Key Manufacturers (2018-2023)

    Table 5. Global Urology Drugs Sales Market Share by Manufacturers (2018-2023)

    Table 6. Global Urology Drugs Revenue (US$ Million) by Manufacturers (2018-2023)

    Table 7. Global Urology Drugs Revenue Share by Manufacturers (2018-2023)

    Table 8. Global Market Urology Drugs Average Price (USD/Kg) of Key Manufacturers (2018-2023)

    Table 9. Global Key Players of Urology Drugs, Industry Ranking, 2021 VS 2022 VS 2023

    Table 10. Global Key Manufacturers of Urology Drugs, Manufacturing Sites & Headquarters

    Table 11. Global Key Manufacturers of Urology Drugs, Product Type & Application

    Table 12. Global Key Manufacturers of Urology Drugs, Date of Enter into This Industry

    Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

    Table 14. Global Urology Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Urology Drugs as of 2022)

    Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

    Table 16. Global Urology Drugs Market Size by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 17. Global Urology Drugs Sales by Region (2018-2023) & (MT)

    Table 18. Global Urology Drugs Sales Market Share by Region (2018-2023)

    Table 19. Global Urology Drugs Sales by Region (2024-2029) & (MT)

    Table 20. Global Urology Drugs Sales Market Share by Region (2024-2029)

    Table 21. Global Urology Drugs Revenue by Region (2018-2023) & (US$ Million)

    Table 22. Global Urology Drugs Revenue Market Share by Region (2018-2023)

    Table 23. Global Urology Drugs Revenue by Region (2024-2029) & (US$ Million)

    Table 24. Global Urology Drugs Revenue Market Share by Region (2024-2029)

    Table 25. North America Urology Drugs Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)

    Table 26. North America Urology Drugs Sales by Country (2018-2023) & (MT)

    Table 27. North America Urology Drugs Sales by Country (2024-2029) & (MT)

    Table 28. North America Urology Drugs Revenue by Country (2018-2023) & (US$ Million)

    Table 29. North America Urology Drugs Revenue by Country (2024-2029) & (US$ Million)

    Table 30. Europe Urology Drugs Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)

    Table 31. Europe Urology Drugs Sales by Country (2018-2023) & (MT)

    Table 32. Europe Urology Drugs Sales by Country (2024-2029) & (MT)

    Table 33. Europe Urology Drugs Revenue by Country (2018-2023) & (US$ Million)

    Table 34. Europe Urology Drugs Revenue by Country (2024-2029) & (US$ Million)

    Table 35. Asia Pacific Urology Drugs Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)

    Table 36. Asia Pacific Urology Drugs Sales by Region (2018-2023) & (MT)

    Table 37. Asia Pacific Urology Drugs Sales by Region (2024-2029) & (MT)

    Table 38. Asia Pacific Urology Drugs Revenue by Region (2018-2023) & (US$ Million)

    Table 39. Asia Pacific Urology Drugs Revenue by Region (2024-2029) & (US$ Million)

    Table 40. Latin America Urology Drugs Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)

    Table 41. Latin America Urology Drugs Sales by Country (2018-2023) & (MT)

    Table 42. Latin America Urology Drugs Sales by Country (2024-2029) & (MT)

    Table 43. Latin America Urology Drugs Revenue by Country (2018-2023) & (US$ Million)

    Table 44. Latin America Urology Drugs Revenue by Country (2024-2029) & (US$ Million)

    Table 45. Middle East & Africa Urology Drugs Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)

    Table 46. Middle East & Africa Urology Drugs Sales by Country (2018-2023) & (MT)

    Table 47. Middle East & Africa Urology Drugs Sales by Country (2024-2029) & (MT)

    Table 48. Middle East & Africa Urology Drugs Revenue by Country (2018-2023) & (US$ Million)

    Table 49. Middle East & Africa Urology Drugs Revenue by Country (2024-2029) & (US$ Million)

    Table 50. Global Urology Drugs Sales (MT) by Type (2018-2023)

    Table 51. Global Urology Drugs Sales (MT) by Type (2024-2029)

    Table 52. Global Urology Drugs Sales Market Share by Type (2018-2023)

    Table 53. Global Urology Drugs Sales Market Share by Type (2024-2029)

    Table 54. Global Urology Drugs Revenue (US$ Million) by Type (2018-2023)

    Table 55. Global Urology Drugs Revenue (US$ Million) by Type (2024-2029)

    Table 56. Global Urology Drugs Revenue Market Share by Type (2018-2023)

    Table 57. Global Urology Drugs Revenue Market Share by Type (2024-2029)

    Table 58. Global Urology Drugs Price (USD/Kg) by Type (2018-2023)

    Table 59. Global Urology Drugs Price (USD/Kg) by Type (2024-2029)

    Table 60. Global Urology Drugs Sales (MT) by Application (2018-2023)

    Table 61. Global Urology Drugs Sales (MT) by Application (2024-2029)

    Table 62. Global Urology Drugs Sales Market Share by Application (2018-2023)

    Table 63. Global Urology Drugs Sales Market Share by Application (2024-2029)

    Table 64. Global Urology Drugs Revenue (US$ Million) by Application (2018-2023)

    Table 65. Global Urology Drugs Revenue (US$ Million) by Application (2024-2029)

    Table 66. Global Urology Drugs Revenue Market Share by Application (2018-2023)

    Table 67. Global Urology Drugs Revenue Market Share by Application (2024-2029)

    Table 68. Global Urology Drugs Price (USD/Kg) by Application (2018-2023)

    Table 69. Global Urology Drugs Price (USD/Kg) by Application (2024-2029)

    Table 70. Astellas Corporation Information

    Table 71. Astellas Description and Business Overview

    Table 72. Astellas Urology Drugs Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2023)

    Table 73. Astellas Urology Drugs Product

    Table 74. Astellas Recent Developments/Updates

    Table 75. Endo Corporation Information

    Table 76. Endo Description and Business Overview

    Table 77. Endo Urology Drugs Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2023)

    Table 78. Endo Urology Drugs Product

    Table 79. Endo Recent Developments/Updates

    Table 80. GP Pharm Corporation Information

    Table 81. GP Pharm Description and Business Overview

    Table 82. GP Pharm Urology Drugs Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2023)

    Table 83. GP Pharm Urology Drugs Product

    Table 84. GP Pharm Recent Developments/Updates

    Table 85. Tolmar Corporation Information

    Table 86. Tolmar Description and Business Overview

    Table 87. Tolmar Urology Drugs Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2023)

    Table 88. Tolmar Urology Drugs Product

    Table 89. Tolmar Recent Developments/Updates

    Table 90. Key Raw Materials Lists

    Table 91. Raw Materials Key Suppliers Lists

    Table 92. Urology Drugs Distributors List

    Table 93. Urology Drugs Customers List

    Table 94. Urology Drugs Market Trends

    Table 95. Urology Drugs Market Drivers

    Table 96. Urology Drugs Market Challenges

    Table 97. Urology Drugs Market Restraints

    Table 98. Research Programs/Design for This Report

    Table 99. Key Data Information from Secondary Sources

    Table 100. Key Data Information from Primary Sources

List of Figures

    Figure 1. Product Picture of Urology Drugs

    Figure 2. Global Urology Drugs Market Value Comparison by Type (2023-2029) & (US$ Million)

    Figure 3. Global Urology Drugs Market Share by Type in 2022 & 2029

    Figure 4. Α (alpha) Blockers Product Picture

    Figure 5. 5 α-reductase Inhibitors Product Picture

    Figure 6. Global Urology Drugs Market Value Comparison by Application (2023-2029) & (US$ Million)

    Figure 7. Global Urology Drugs Market Share by Application in 2022 & 2029

    Figure 8. Hospital

    Figure 9. Clinic

    Figure 10. Others

    Figure 11. Global Urology Drugs Revenue, (US$ Million), 2018 VS 2022 VS 2029

    Figure 12. Global Urology Drugs Market Size (2018-2029) & (US$ Million)

    Figure 13. Global Urology Drugs Sales (2018-2029) & (MT)

    Figure 14. Global Urology Drugs Average Price (USD/Kg) & (2018-2029)

    Figure 15. Urology Drugs Report Years Considered

    Figure 16. Urology Drugs Sales Share by Manufacturers in 2022

    Figure 17. Global Urology Drugs Revenue Share by Manufacturers in 2022

    Figure 18. The Global 5 and 10 Largest Urology Drugs Players: Market Share by Revenue in 2022

    Figure 19. Urology Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022

    Figure 20. Global Urology Drugs Market Size by Region (US$ Million): 2018 VS 2022 VS 2029

    Figure 21. North America Urology Drugs Sales Market Share by Country (2018-2029)

    Figure 22. North America Urology Drugs Revenue Market Share by Country (2018-2029)

    Figure 23. U.S. Urology Drugs Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 24. Canada Urology Drugs Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 25. Europe Urology Drugs Sales Market Share by Country (2018-2029)

    Figure 26. Europe Urology Drugs Revenue Market Share by Country (2018-2029)

    Figure 27. Germany Urology Drugs Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 28. France Urology Drugs Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 29. U.K. Urology Drugs Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 30. Italy Urology Drugs Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 31. Russia Urology Drugs Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 32. Asia Pacific Urology Drugs Sales Market Share by Region (2018-2029)

    Figure 33. Asia Pacific Urology Drugs Revenue Market Share by Region (2018-2029)

    Figure 34. China Urology Drugs Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 35. Japan Urology Drugs Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 36. South Korea Urology Drugs Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 37. India Urology Drugs Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 38. Australia Urology Drugs Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 39. Taiwan Urology Drugs Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 40. Indonesia Urology Drugs Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 41. Thailand Urology Drugs Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 42. Malaysia Urology Drugs Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 43. Philippines Urology Drugs Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 44. Latin America Urology Drugs Sales Market Share by Country (2018-2029)

    Figure 45. Latin America Urology Drugs Revenue Market Share by Country (2018-2029)

    Figure 46. Mexico Urology Drugs Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 47. Brazil Urology Drugs Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 48. Argentina Urology Drugs Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 49. Middle East & Africa Urology Drugs Sales Market Share by Country (2018-2029)

    Figure 50. Middle East & Africa Urology Drugs Revenue Market Share by Country (2018-2029)

    Figure 51. Turkey Urology Drugs Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 52. Saudi Arabia Urology Drugs Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 53. U.A.E Urology Drugs Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 54. Global Sales Market Share of Urology Drugs by Type (2018-2029)

    Figure 55. Global Revenue Market Share of Urology Drugs by Type (2018-2029)

    Figure 56. Global Urology Drugs Price (USD/Kg) by Type (2018-2029)

    Figure 57. Global Sales Market Share of Urology Drugs by Application (2018-2029)

    Figure 58. Global Revenue Market Share of Urology Drugs by Application (2018-2029)

    Figure 59. Global Urology Drugs Price (USD/Kg) by Application (2018-2029)

    Figure 60. Urology Drugs Value Chain

    Figure 61. Urology Drugs Production Process

    Figure 62. Channels of Distribution (Direct Vs Distribution)

    Figure 63. Distributors Profiles

    Figure 64. Bottom-up and Top-down Approaches for This Report

    Figure 65. Data Triangulation

    Figure 66. Key Executives Interviewed